| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 PHKA1 PHKA2 RPS6KA6 CDKL4 GSK3A GSK3B MAP4K1 CHEK2 ATM | 7.39e-06 | 446 | 193 | 16 | GO:0004674 |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 3.47e-05 | 207 | 193 | 10 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 4.25e-05 | 212 | 193 | 10 | GO:0017171 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 RPS6KA6 CDKL4 GSK3A GSK3B MAP4K1 CHEK2 ATM | 5.53e-05 | 363 | 193 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | protein kinase activity | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 PHKA1 PHKA2 RPS6KA6 CAD CDKL4 GSK3A GSK3B MAP4K1 CHEK2 ATM | 7.70e-05 | 600 | 193 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | histone acetyltransferase regulator activity | 9.29e-05 | 2 | 193 | 2 | GO:0035034 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 9.97e-05 | 190 | 193 | 9 | GO:0004252 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 1.83e-04 | 12 | 193 | 3 | GO:0001851 | |
| GeneOntologyMolecularFunction | phenanthrene-9,10-epoxide hydrolase activity | 2.77e-04 | 3 | 193 | 2 | GO:0019119 | |
| GeneOntologyMolecularFunction | phenanthrene-epoxide hydrolase activity | 2.77e-04 | 3 | 193 | 2 | GO:0019118 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 PHKA1 PHKA2 RPS6KA6 CAD CDKL4 GSK3A GSK3B MAP4K1 CHEK2 ATM | 5.44e-04 | 709 | 193 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 5.47e-04 | 17 | 193 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 5.47e-04 | 17 | 193 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | glucosylceramidase activity | 5.51e-04 | 4 | 193 | 2 | GO:0004348 | |
| GeneOntologyMolecularFunction | phosphorylase kinase activity | 5.51e-04 | 4 | 193 | 2 | GO:0004689 | |
| GeneOntologyMolecularFunction | galactosylceramidase activity | 9.12e-04 | 5 | 193 | 2 | GO:0004336 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 9.12e-04 | 5 | 193 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | kinase activity | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 PHKA1 PHKA2 RPS6KA6 CAD CDKL4 GSK3A GSK3B MAP4K1 CHEK2 ATM | 1.24e-03 | 764 | 193 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | beta-glucosidase activity | 1.36e-03 | 6 | 193 | 2 | GO:0008422 | |
| GeneOntologyMolecularFunction | virus receptor activity | 1.41e-03 | 85 | 193 | 5 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.48e-03 | 86 | 193 | 5 | GO:0140272 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.75e-03 | 25 | 193 | 3 | GO:0001846 | |
| GeneOntologyBiologicalProcess | regulation of MyD88-dependent toll-like receptor signaling pathway | 3.06e-06 | 4 | 190 | 3 | GO:0034124 | |
| GeneOntologyBiologicalProcess | complement activation | 3.70e-06 | 70 | 190 | 7 | GO:0006956 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF, modulating synaptic transmission | 2.62e-05 | 7 | 190 | 3 | GO:0099183 | |
| GeneOntologyBiologicalProcess | blood coagulation | 3.08e-05 | 260 | 190 | 11 | GO:0007596 | |
| GeneOntologyBiologicalProcess | coagulation | 3.80e-05 | 266 | 190 | 11 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 4.06e-05 | 268 | 190 | 11 | GO:0007599 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF | 4.16e-05 | 8 | 190 | 3 | GO:0099191 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 5.11e-05 | 44 | 190 | 5 | GO:0006958 | |
| GeneOntologyBiologicalProcess | positive regulation of wound healing | 5.76e-05 | 73 | 190 | 6 | GO:0090303 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | HMCN2 NECTIN2 ROBO3 SDK1 SDK2 PCDHB11 PCDHAC1 PTPRT PCDHGA12 | 6.13e-05 | 187 | 190 | 9 | GO:0007156 |
| GeneOntologyBiologicalProcess | cleavage furrow ingression | 8.44e-05 | 2 | 190 | 2 | GO:0036090 | |
| GeneOntologyBiologicalProcess | negative regulation of MyD88-dependent toll-like receptor signaling pathway | 8.44e-05 | 2 | 190 | 2 | GO:0034125 | |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 1.26e-04 | 53 | 190 | 5 | GO:1902041 | |
| GeneOntologyBiologicalProcess | fibrinolysis | 1.38e-04 | 29 | 190 | 4 | GO:0042730 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 1.56e-04 | 166 | 190 | 8 | GO:0061041 | |
| GeneOntologyBiologicalProcess | positive regulation of blood coagulation | 1.81e-04 | 31 | 190 | 4 | GO:0030194 | |
| GeneOntologyBiologicalProcess | positive regulation of hemostasis | 1.81e-04 | 31 | 190 | 4 | GO:1900048 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 1.97e-04 | 91 | 190 | 6 | GO:0030193 | |
| GeneOntologyBiologicalProcess | wound healing | CFH MYLK HPSE LYST F13A1 SVEP1 MAP3K1 VPS33B PLAT FGG PLG KNG1 LPA OCLN | 2.01e-04 | 493 | 190 | 14 | GO:0042060 |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 2.21e-04 | 93 | 190 | 6 | GO:1903036 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 2.21e-04 | 93 | 190 | 6 | GO:1900046 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | CFH HPSE LYST F13A1 SVEP1 VPS33B PLAT FGG PLG KNG1 CAD LPA HYAL2 | 2.42e-04 | 442 | 190 | 13 | GO:0050878 |
| GeneOntologyBiologicalProcess | negative regulation of type B pancreatic cell development | 2.52e-04 | 3 | 190 | 2 | GO:2000077 | |
| GeneOntologyBiologicalProcess | negative regulation of glycogen (starch) synthase activity | 2.52e-04 | 3 | 190 | 2 | GO:2000466 | |
| GeneOntologyBiologicalProcess | protein targeting to Golgi apparatus | 2.52e-04 | 3 | 190 | 2 | GO:0140450 | |
| GeneOntologyBiologicalProcess | negative regulation of fibrinolysis | 2.60e-04 | 14 | 190 | 3 | GO:0051918 | |
| GeneOntologyBiologicalProcess | positive regulation of coagulation | 2.61e-04 | 34 | 190 | 4 | GO:0050820 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in embryonic placenta development | 2.61e-04 | 34 | 190 | 4 | GO:0060706 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 2.63e-04 | 96 | 190 | 6 | GO:0050818 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 2.66e-04 | 62 | 190 | 5 | GO:0002455 | |
| GeneOntologyBiologicalProcess | zymogen activation | 3.32e-04 | 65 | 190 | 5 | GO:0031638 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 3.42e-04 | 235 | 190 | 9 | GO:0016064 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 4.39e-04 | 69 | 190 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 4.50e-04 | 244 | 190 | 9 | GO:0019724 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 4.69e-04 | 70 | 190 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | metanephric proximal tubule development | 5.00e-04 | 4 | 190 | 2 | GO:0072237 | |
| GeneOntologyBiologicalProcess | pre-B cell allelic exclusion | 5.00e-04 | 4 | 190 | 2 | GO:0002331 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 5.34e-04 | 72 | 190 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of canonical Wnt signaling pathway | 5.73e-04 | 154 | 190 | 7 | GO:0090090 | |
| GeneOntologyBiologicalProcess | protein catabolic process | HSP90B2P PRSS16 CBLC HPSE USP19 MAP3K1 PSME4 ASB11 HERC2 PLG DCAF12 SEL1L GSK3A GSK3B FEM1B RNF123 SF3B3 PREP LPA CHEK2 ATM CTSO | 6.29e-04 | 1115 | 190 | 22 | GO:0030163 |
| GeneOntologyBiologicalProcess | regulation of fibrinolysis | 6.69e-04 | 19 | 190 | 3 | GO:0051917 | |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 6.69e-04 | 19 | 190 | 3 | GO:0006957 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 3.50e-06 | 12 | 196 | 4 | GO:0044666 | |
| GeneOntologyCellularComponent | external side of plasma membrane | CFH FCRL2 FCGR1A CD163L1 BTN1A1 CLPTM1 TRPM8 FGG PLG CR1 LPA IGHM FCRL4 LY75 HYAL2 | 1.20e-04 | 519 | 196 | 15 | GO:0009897 |
| MousePheno | abnormal optic choroid morphology | 2.02e-05 | 52 | 152 | 6 | MP:0005098 | |
| MousePheno | abnormal circulating fibrinogen level | 6.78e-05 | 8 | 152 | 3 | MP:0010213 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 1.17e-04 | 2 | 152 | 2 | MP:0009507 | |
| MousePheno | ectropion | 1.17e-04 | 2 | 152 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 1.17e-04 | 2 | 152 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 1.17e-04 | 2 | 152 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 1.17e-04 | 2 | 152 | 2 | MP:0005035 | |
| MousePheno | abnormal acute phase protein level | 1.42e-04 | 25 | 152 | 4 | MP:0010211 | |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 1.43e-04 | 10 | 152 | 3 | MP:0003434 | |
| MousePheno | abnormal kidney thrombosis | 1.43e-04 | 10 | 152 | 3 | MP:0011507 | |
| Domain | WD40_repeat_dom | AAMP DCAF6 AHI1 EML6 COPB2 ARHGEF17 LYST BRWD3 WDR38 CIAO1 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 SF3B3 TLE2 WDFY3 | 2.30e-10 | 297 | 191 | 19 | IPR017986 |
| Domain | WD40_repeat | AAMP DCAF6 AHI1 EML6 COPB2 LYST BRWD3 WDR38 CIAO1 HERC2 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 TLE2 WDFY3 | 4.07e-10 | 272 | 191 | 18 | IPR001680 |
| Domain | WD_REPEATS_1 | AAMP DCAF6 AHI1 EML6 COPB2 LYST BRWD3 WDR38 CIAO1 HERC2 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 TLE2 WDFY3 | 5.79e-10 | 278 | 191 | 18 | PS00678 |
| Domain | WD_REPEATS_2 | AAMP DCAF6 AHI1 EML6 COPB2 LYST BRWD3 WDR38 CIAO1 HERC2 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 TLE2 WDFY3 | 6.13e-10 | 279 | 191 | 18 | PS50082 |
| Domain | WD_REPEATS_REGION | AAMP DCAF6 AHI1 EML6 COPB2 LYST BRWD3 WDR38 CIAO1 HERC2 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 TLE2 WDFY3 | 6.13e-10 | 279 | 191 | 18 | PS50294 |
| Domain | WD40 | AAMP DCAF6 AHI1 EML6 COPB2 LYST BRWD3 WDR38 CIAO1 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 TLE2 WDFY3 | 1.45e-09 | 259 | 191 | 17 | PF00400 |
| Domain | WD40_repeat_CS | AAMP EML6 LYST BRWD3 WDR38 CIAO1 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 TLE2 WDFY3 | 1.47e-09 | 164 | 191 | 14 | IPR019775 |
| Domain | WD40/YVTN_repeat-like_dom | AAMP DCAF6 AHI1 EML6 COPB2 ARHGEF17 LYST BRWD3 WDR38 CIAO1 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 SF3B3 TLE2 WDFY3 | 1.74e-09 | 335 | 191 | 19 | IPR015943 |
| Domain | IG | FCRL2 MYLK CD300A OBSCN NCAM2 CD300C HMCN2 FCGR1A BTN1A1 NECTIN2 ROBO3 SDK1 SDK2 CD300LF MYOM3 PTPRT LSR CD300LD MYOM2 FCRL4 CD300E | 2.33e-09 | 421 | 191 | 21 | SM00409 |
| Domain | Ig_sub | FCRL2 MYLK CD300A OBSCN NCAM2 CD300C HMCN2 FCGR1A BTN1A1 NECTIN2 ROBO3 SDK1 SDK2 CD300LF MYOM3 PTPRT LSR CD300LD MYOM2 FCRL4 CD300E | 2.33e-09 | 421 | 191 | 21 | IPR003599 |
| Domain | WD40 | AAMP DCAF6 AHI1 EML6 COPB2 LYST BRWD3 WDR38 CIAO1 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 TLE2 WDFY3 | 2.43e-09 | 268 | 191 | 17 | SM00320 |
| Domain | Ig-like_fold | FCRL2 MYLK CD300A OBSCN PHYHIP NCAM2 F13A1 CD300C HMCN2 FCGR1A PTPRH BTN1A1 NECTIN2 ROBO3 USH2A SDK1 SDK2 CD300LF MYOM3 PTPRT LSR CD300LD IGHM MYOM2 FCRL4 CD300E EPB42 | 3.55e-09 | 706 | 191 | 27 | IPR013783 |
| Domain | IG_LIKE | FCRL2 MYLK CD300A OBSCN NCAM2 CD300C HMCN2 FCGR1A BTN1A1 NECTIN2 ROBO3 SDK1 SDK2 CD300LF MYOM3 PTPRT LSR CD300LD IGHM MYOM2 FCRL4 CD300E | 6.80e-09 | 491 | 191 | 22 | PS50835 |
| Domain | - | AAMP DCAF6 AHI1 EML6 COPB2 ARHGEF17 LYST BRWD3 WDR38 CIAO1 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 TLE2 WDFY3 | 1.01e-08 | 333 | 191 | 18 | 2.130.10.10 |
| Domain | Ig-like_dom | FCRL2 MYLK CD300A OBSCN NCAM2 CD300C HMCN2 FCGR1A BTN1A1 NECTIN2 ROBO3 SDK1 SDK2 CD300LF MYOM3 PTPRT LSR CD300LD IGHM MYOM2 FCRL4 CD300E | 1.05e-08 | 503 | 191 | 22 | IPR007110 |
| Domain | Kringle-like | 2.84e-08 | 32 | 191 | 7 | IPR013806 | |
| Domain | FN3 | MYLK KIAA0319L OBSCN PHYHIP NCAM2 PTPRH ROBO3 USH2A SDK1 SDK2 MYOM3 PTPRT MYOM2 | 5.94e-08 | 185 | 191 | 13 | SM00060 |
| Domain | - | FCRL2 MYLK CD300A OBSCN PHYHIP NCAM2 F13A1 CD300C FCGR1A BTN1A1 NECTIN2 ROBO3 USH2A SDK1 SDK2 CD300LF MYOM3 PTPRT LSR CD300LD MYOM2 FCRL4 CD300E EPB42 | 7.99e-08 | 663 | 191 | 24 | 2.60.40.10 |
| Domain | fn3 | MYLK OBSCN PHYHIP NCAM2 PTPRH ROBO3 USH2A SDK1 SDK2 MYOM3 PTPRT MYOM2 | 1.09e-07 | 162 | 191 | 12 | PF00041 |
| Domain | FN3_dom | MYLK KIAA0319L OBSCN PHYHIP NCAM2 PTPRH ROBO3 USH2A SDK1 SDK2 MYOM3 PTPRT MYOM2 | 2.47e-07 | 209 | 191 | 13 | IPR003961 |
| Domain | Kringle_CS | 5.94e-07 | 17 | 191 | 5 | IPR018056 | |
| Domain | KRINGLE_1 | 5.94e-07 | 17 | 191 | 5 | PS00021 | |
| Domain | KR | 5.94e-07 | 17 | 191 | 5 | SM00130 | |
| Domain | Kringle | 5.94e-07 | 17 | 191 | 5 | IPR000001 | |
| Domain | KRINGLE_2 | 5.94e-07 | 17 | 191 | 5 | PS50070 | |
| Domain | Kringle | 5.94e-07 | 17 | 191 | 5 | PF00051 | |
| Domain | FN3 | MYLK OBSCN PHYHIP NCAM2 PTPRH ROBO3 USH2A SDK1 SDK2 MYOM3 PTPRT MYOM2 | 1.01e-06 | 199 | 191 | 12 | PS50853 |
| Domain | Sushi_SCR_CCP_dom | 1.80e-06 | 57 | 191 | 7 | IPR000436 | |
| Domain | IGc2 | FCRL2 MYLK OBSCN NCAM2 HMCN2 FCGR1A ROBO3 SDK1 SDK2 MYOM3 MYOM2 FCRL4 | 5.67e-06 | 235 | 191 | 12 | SM00408 |
| Domain | Ig_sub2 | FCRL2 MYLK OBSCN NCAM2 HMCN2 FCGR1A ROBO3 SDK1 SDK2 MYOM3 MYOM2 FCRL4 | 5.67e-06 | 235 | 191 | 12 | IPR003598 |
| Domain | CUB | 1.03e-05 | 49 | 191 | 6 | PF00431 | |
| Domain | TRYPSIN_HIS | 1.07e-05 | 103 | 191 | 8 | IPR018114 | |
| Domain | CUB | 1.16e-05 | 50 | 191 | 6 | SM00042 | |
| Domain | TRYPSIN_SER | 1.32e-05 | 106 | 191 | 8 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.42e-05 | 107 | 191 | 8 | PS00134 | |
| Domain | - | 1.46e-05 | 52 | 191 | 6 | 2.60.120.290 | |
| Domain | Sushi | 1.46e-05 | 52 | 191 | 6 | PF00084 | |
| Domain | CUB | 1.63e-05 | 53 | 191 | 6 | PS01180 | |
| Domain | CCP | 1.82e-05 | 54 | 191 | 6 | SM00032 | |
| Domain | Peptidase_S1A | 2.12e-05 | 113 | 191 | 8 | IPR001314 | |
| Domain | SUSHI | 2.24e-05 | 56 | 191 | 6 | PS50923 | |
| Domain | TRYPSIN_DOM | 2.40e-05 | 115 | 191 | 8 | PS50240 | |
| Domain | CUB_dom | 2.49e-05 | 57 | 191 | 6 | IPR000859 | |
| Domain | Ig_I-set | 2.67e-05 | 190 | 191 | 10 | IPR013098 | |
| Domain | I-set | 2.67e-05 | 190 | 191 | 10 | PF07679 | |
| Domain | Tryp_SPc | 2.72e-05 | 117 | 191 | 8 | SM00020 | |
| Domain | Trypsin_dom | 3.47e-05 | 121 | 191 | 8 | IPR001254 | |
| Domain | Trypsin | 3.47e-05 | 121 | 191 | 8 | PF00089 | |
| Domain | Peptidase_S1_PA | 3.90e-05 | 123 | 191 | 8 | IPR009003 | |
| Domain | Ig_V-set | FCRL2 CD300A OBSCN NCAM2 CD300C BTN1A1 NECTIN2 CD300LF CD300LD CD300E | 3.97e-05 | 199 | 191 | 10 | IPR013106 |
| Domain | SRCR | 5.54e-05 | 21 | 191 | 4 | PF00530 | |
| Domain | Ser/Thr_kinase_AS | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 RPS6KA6 CDKL4 GSK3A GSK3B MAP4K1 CHEK2 | 8.19e-05 | 357 | 191 | 13 | IPR008271 |
| Domain | S_TKc | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 RPS6KA6 CDKL4 GSK3A GSK3B MAP4K1 CHEK2 | 8.66e-05 | 359 | 191 | 13 | SM00220 |
| Domain | PROTEIN_KINASE_ST | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 RPS6KA6 CDKL4 GSK3A GSK3B MAP4K1 CHEK2 | 9.41e-05 | 362 | 191 | 13 | PS00108 |
| Domain | Mst1_SARAH_domain | 1.04e-04 | 2 | 191 | 2 | IPR024205 | |
| Domain | Mst1_SARAH | 1.04e-04 | 2 | 191 | 2 | PF11629 | |
| Domain | GPP34 | 1.04e-04 | 2 | 191 | 2 | IPR008628 | |
| Domain | GPP34 | 1.04e-04 | 2 | 191 | 2 | PF05719 | |
| Domain | - | 1.13e-04 | 25 | 191 | 4 | 3.10.250.10 | |
| Domain | SR | 1.13e-04 | 25 | 191 | 4 | SM00202 | |
| Domain | SRCR-like_dom | 1.33e-04 | 26 | 191 | 4 | IPR017448 | |
| Domain | SRCR_1 | 1.33e-04 | 26 | 191 | 4 | PS00420 | |
| Domain | SRCR_2 | 1.33e-04 | 26 | 191 | 4 | PS50287 | |
| Domain | SRCR | 1.55e-04 | 27 | 191 | 4 | IPR001190 | |
| Domain | Pkinase | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 RPS6KA6 CDKL4 GSK3A GSK3B MAP4K1 CHEK2 | 1.56e-04 | 381 | 191 | 13 | PF00069 |
| Domain | 6-hairpin_glycosidase-like | 2.79e-04 | 13 | 191 | 3 | IPR008928 | |
| Domain | Glyco_hydro_15/PHK | 3.10e-04 | 3 | 191 | 2 | IPR011613 | |
| Domain | PHK_A/B_su | 3.10e-04 | 3 | 191 | 2 | IPR008734 | |
| Domain | Glyco_hydro_15 | 3.10e-04 | 3 | 191 | 2 | PF00723 | |
| Domain | TRYPSIN_SER | 3.23e-04 | 90 | 191 | 6 | IPR033116 | |
| Domain | EamA | 3.53e-04 | 14 | 191 | 3 | PF00892 | |
| Domain | EamA_dom | 3.53e-04 | 14 | 191 | 3 | IPR000620 | |
| Domain | Kinase-like_dom | MYLK RAPH1 RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 RPS6KA6 CDKL4 GSK3A GSK3B MAP4K1 CHEK2 ATM | 4.74e-04 | 542 | 191 | 15 | IPR011009 |
| Domain | V-set | 6.24e-04 | 184 | 191 | 8 | PF07686 | |
| Domain | Acyl_Trfase/lysoPLipase | 6.44e-04 | 17 | 191 | 3 | IPR016035 | |
| Domain | ig | 7.70e-04 | 190 | 191 | 8 | PF00047 | |
| Domain | Immunoglobulin | 7.70e-04 | 190 | 191 | 8 | IPR013151 | |
| Domain | PROTEIN_KINASE_ATP | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 RPS6KA6 CDKL4 GSK3A GSK3B MAP4K1 CHEK2 | 9.14e-04 | 459 | 191 | 13 | PS00107 |
| Domain | FYrich_C | 1.02e-03 | 5 | 191 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.02e-03 | 5 | 191 | 2 | IPR003888 | |
| Domain | FYRC | 1.02e-03 | 5 | 191 | 2 | SM00542 | |
| Domain | FYRN | 1.02e-03 | 5 | 191 | 2 | SM00541 | |
| Domain | FYRN | 1.02e-03 | 5 | 191 | 2 | PF05964 | |
| Domain | FYRC | 1.02e-03 | 5 | 191 | 2 | PF05965 | |
| Domain | FYRC | 1.02e-03 | 5 | 191 | 2 | PS51543 | |
| Domain | FYRN | 1.02e-03 | 5 | 191 | 2 | PS51542 | |
| Domain | RCC1 | 1.06e-03 | 20 | 191 | 3 | PF00415 | |
| Domain | RCC1_1 | 1.22e-03 | 21 | 191 | 3 | PS00625 | |
| Domain | RCC1_2 | 1.22e-03 | 21 | 191 | 3 | PS00626 | |
| Domain | RCC1_3 | 1.22e-03 | 21 | 191 | 3 | PS50012 | |
| Domain | - | 1.40e-03 | 22 | 191 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 1.40e-03 | 22 | 191 | 3 | IPR000408 | |
| Domain | PH_BEACH | 1.52e-03 | 6 | 191 | 2 | PF14844 | |
| Domain | Ribosomal_S6_kinase_II | 1.52e-03 | 6 | 191 | 2 | IPR016239 | |
| Domain | RCC1/BLIP-II | 1.60e-03 | 23 | 191 | 3 | IPR009091 | |
| Domain | Prot_kinase_dom | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 RPS6KA6 CDKL4 GSK3A GSK3B MAP4K1 CHEK2 | 1.61e-03 | 489 | 191 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 RPS6KA6 CDKL4 GSK3A GSK3B MAP4K1 CHEK2 | 1.73e-03 | 493 | 191 | 13 | PS50011 |
| Domain | G-protein_beta_WD-40_rep | 1.80e-03 | 85 | 191 | 5 | IPR020472 | |
| Domain | Protein_kinase_ATP_BS | MYLK RPS6KA5 CDK15 OBSCN MAP3K1 STK3 STK4 RPS6KA6 GSK3A GSK3B MAP4K1 | 1.86e-03 | 379 | 191 | 11 | IPR017441 |
| Domain | ConA-like_dom | 1.91e-03 | 219 | 191 | 8 | IPR013320 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 3.66e-08 | 12 | 124 | 5 | MM1398 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 1.52e-07 | 69 | 124 | 8 | M16894 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 2.67e-06 | 12 | 124 | 4 | M2842 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 1.14e-05 | 58 | 124 | 6 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 1.26e-05 | 59 | 124 | 6 | M48343 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 2.12e-05 | 132 | 124 | 8 | M39338 | |
| Pathway | WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION | 2.27e-05 | 7 | 124 | 3 | M39868 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 4.44e-05 | 23 | 124 | 4 | MM15936 | |
| Pathway | WP_INSULIN_SIGNALING | 8.35e-05 | 160 | 124 | 8 | M39482 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 2.16e-04 | 34 | 124 | 4 | MM15985 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.25e-04 | 14 | 124 | 3 | MM1458 | |
| Pathway | REACTOME_DISSOLUTION_OF_FIBRIN_CLOT | 2.80e-04 | 15 | 124 | 3 | MM15450 | |
| Pathway | WP_BDNF_PATHWAY | 3.42e-04 | 16 | 124 | 3 | MM15816 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 4.08e-04 | 40 | 124 | 4 | M39595 | |
| Pubmed | 3.31e-11 | 6 | 197 | 5 | 29051512 | ||
| Pubmed | The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. | 1.15e-10 | 7 | 197 | 5 | 19359216 | |
| Pubmed | The CD300 molecules regulate monocyte and dendritic cell functions. | 1.15e-10 | 7 | 197 | 5 | 19592130 | |
| Pubmed | CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. | 6.87e-09 | 13 | 197 | 5 | 14662855 | |
| Pubmed | CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. | 1.48e-08 | 6 | 197 | 4 | 20959446 | |
| Pubmed | Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation. | 1.48e-08 | 6 | 197 | 4 | 31101623 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 16818777 | ||
| Pubmed | Lack of plasminogen leads to milk stasis and premature mammary gland involution during lactation. | 1.79e-07 | 3 | 197 | 3 | 16949567 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 17717150 | ||
| Pubmed | Neuronal death and blood-brain barrier breakdown after excitotoxic injury are independent processes. | 1.79e-07 | 3 | 197 | 3 | 10559390 | |
| Pubmed | Pneumococcal phosphoglycerate kinase interacts with plasminogen and its tissue activator. | 1.79e-07 | 3 | 197 | 3 | 24196407 | |
| Pubmed | Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. | 1.79e-07 | 3 | 197 | 3 | 12524546 | |
| Pubmed | Plasmin-driven fibrinolysis facilitates skin tumor growth in a gender-dependent manner. | 1.79e-07 | 3 | 197 | 3 | 22815383 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 33827130 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 24612416 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 15630096 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 16330749 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 14988509 | ||
| Pubmed | An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. | 1.79e-07 | 3 | 197 | 3 | 8987777 | |
| Pubmed | The hippocampal laminin matrix is dynamic and critical for neuronal survival. | 1.79e-07 | 3 | 197 | 3 | 12857855 | |
| Pubmed | Tissue plasminogen activator promotes axonal outgrowth on CNS myelin after conditioned injury. | 1.79e-07 | 3 | 197 | 3 | 19220707 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 15522965 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ALKBH4 SIPA1L3 KIAA0319L OBSCN IPP CBLC LYST KMT2C FASN ZNF276 PSME4 HERC2 HERC1 CRYBG2 HECTD4 MYOM3 MED13L GBA2 KMT2D PLA2G4B NISCH WDFY3 | 3.66e-07 | 1105 | 197 | 22 | 35748872 |
| Pubmed | 4.00e-07 | 162 | 197 | 9 | 25826454 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 19210287 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 18042398 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 20175210 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 9056918 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 24664548 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 28270519 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 11404420 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 19286661 | ||
| Pubmed | Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice. | 7.13e-07 | 4 | 197 | 3 | 21931850 | |
| Pubmed | A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice. | 7.13e-07 | 4 | 197 | 3 | 32315384 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 9854018 | ||
| Pubmed | CD300 molecule regulation of human dendritic cell functions. | 7.13e-07 | 4 | 197 | 3 | 23072861 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 12070304 | ||
| Pubmed | Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. | 7.13e-07 | 4 | 197 | 3 | 15486301 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 17301181 | ||
| Pubmed | Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. | 7.13e-07 | 4 | 197 | 3 | 16763560 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 21704601 | ||
| Pubmed | Emergence of primate genes by retrotransposon-mediated sequence transduction. | 7.13e-07 | 4 | 197 | 3 | 17101974 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 16505491 | ||
| Pubmed | The effects of the plasminogen pathway on scar tissue formation. | 7.13e-07 | 4 | 197 | 3 | 14709993 | |
| Pubmed | Key role of tissue plasminogen activator in neurovascular coupling. | 7.13e-07 | 4 | 197 | 3 | 18195371 | |
| Pubmed | Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice. | 1.78e-06 | 5 | 197 | 3 | 17596135 | |
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 11557572 | ||
| Pubmed | Fibrinolytic crosstalk with endothelial cells expands murine mesenchymal stromal cells. | 1.78e-06 | 5 | 197 | 3 | 27283026 | |
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 9933568 | ||
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 11306532 | ||
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 12657615 | ||
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 22291008 | ||
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 12875972 | ||
| Pubmed | The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. | 1.78e-06 | 5 | 197 | 3 | 11818362 | |
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 10880388 | ||
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 31857346 | ||
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 8854860 | ||
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 18628488 | ||
| Pubmed | 3.54e-06 | 6 | 197 | 3 | 19147818 | ||
| Pubmed | Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. | 3.54e-06 | 6 | 197 | 3 | 15841177 | |
| Pubmed | 3.54e-06 | 6 | 197 | 3 | 10318667 | ||
| Pubmed | 3.54e-06 | 6 | 197 | 3 | 18337830 | ||
| Pubmed | 4.51e-06 | 20 | 197 | 4 | 19047629 | ||
| Pubmed | MCM9 deficiency delays primordial germ cell proliferation independent of the ATM pathway. | 6.16e-06 | 7 | 197 | 3 | 26388201 | |
| Pubmed | 7.61e-06 | 175 | 197 | 8 | 28071719 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | COPB2 GALNT7 USP19 CDKAL1 FASN CLPTM1 NECTIN2 PLAT TTC13 PLG TARBP1 SEL1L GSK3A GSK3B EXOC8 LSR NISCH OCLN | 7.83e-06 | 942 | 197 | 18 | 31073040 |
| Pubmed | 9.55e-06 | 50 | 197 | 5 | 37974198 | ||
| Pubmed | 9.82e-06 | 8 | 197 | 3 | 8947846 | ||
| Pubmed | 9.82e-06 | 8 | 197 | 3 | 9438420 | ||
| Pubmed | 9.82e-06 | 8 | 197 | 3 | 25893677 | ||
| Pubmed | 9.82e-06 | 8 | 197 | 3 | 11562346 | ||
| Pubmed | 9.82e-06 | 8 | 197 | 3 | 16204191 | ||
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 1.05e-05 | 183 | 197 | 8 | 31932471 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CFH C1RL GALNT7 FASN FCGBP NECTIN2 C1R FGG PLG ALDH1A3 KNG1 HID1 CR1 ARF1 ARF3 AKR7L IGHM CD38 AKR7A3 | 1.22e-05 | 1070 | 197 | 19 | 23533145 |
| Pubmed | Tissue-specific regulation of Igf2r/Airn imprinting during gastrulation. | 1.47e-05 | 9 | 197 | 3 | 25918552 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 1.53e-05 | 139 | 197 | 7 | 25476789 | |
| Pubmed | 1.82e-05 | 325 | 197 | 10 | 36168628 | ||
| Pubmed | 1.83e-05 | 143 | 197 | 7 | 22516433 | ||
| Pubmed | Circulating AIM prevents hepatocellular carcinoma through complement activation. | 2.09e-05 | 10 | 197 | 3 | 25284781 | |
| Pubmed | 2.09e-05 | 10 | 197 | 3 | 37592023 | ||
| Pubmed | Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. | 2.79e-05 | 31 | 197 | 4 | 19344414 | |
| Pubmed | 2.86e-05 | 11 | 197 | 3 | 9268631 | ||
| Pubmed | 2.86e-05 | 11 | 197 | 3 | 8075500 | ||
| Pubmed | A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo. | 2.86e-05 | 11 | 197 | 3 | 26647393 | |
| Pubmed | GOLPH3 and GOLPH3L are broad-spectrum COPI adaptors for sorting into intra-Golgi transport vesicles. | 3.17e-05 | 32 | 197 | 4 | 34473204 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 24523925 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 33607997 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 2474826 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 8226841 | ||
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 3.19e-05 | 2 | 197 | 2 | 10634603 | |
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 3.19e-05 | 2 | 197 | 2 | 23943648 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 3.19e-05 | 2 | 197 | 2 | 7705657 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 16912034 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 23041318 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 24739679 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 25833158 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 12857758 | ||
| Pubmed | Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange. | 3.19e-05 | 2 | 197 | 2 | 16794575 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 19752236 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 16299065 | ||
| Cytoband | 17q25.1 | 6.18e-08 | 81 | 196 | 7 | 17q25.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 5.76e-05 | 307 | 196 | 8 | chr17q25 | |
| Cytoband | 19q13.2 | 7.90e-05 | 164 | 196 | 6 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q42 | 6.12e-04 | 240 | 196 | 6 | chr1q42 | |
| GeneFamily | WD repeat domain containing | AAMP DCAF6 AHI1 EML6 COPB2 LYST BRWD3 WDR38 CIAO1 HERC1 WDR49 ATG16L2 DCAF12 WDR5B WDR7 TLE2 WDFY3 | 1.46e-11 | 262 | 137 | 17 | 362 |
| GeneFamily | Immunoglobulin like domain containing | FCRL2 HMCN2 FCGR1A NECTIN2 ROBO3 SDK1 SDK2 MYOM3 PTPRT LSR MYOM2 FCRL4 | 2.70e-08 | 193 | 137 | 12 | 594 |
| GeneFamily | Fibronectin type III domain containing | MYLK OBSCN NCAM2 PTPRH ROBO3 USH2A SDK1 SDK2 MYOM3 PTPRT MYOM2 | 3.75e-08 | 160 | 137 | 11 | 555 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.37e-07 | 57 | 137 | 7 | 1179 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.81e-06 | 161 | 137 | 9 | 593 | |
| GeneFamily | Complement system|Sushi domain containing | 1.54e-04 | 36 | 137 | 4 | 492 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.45e-04 | 163 | 137 | 7 | 590 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 5.12e-04 | 21 | 137 | 3 | 813 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | FCRL2 CD300A CD300C FCGR1A NECTIN2 CR1 CD38 FCRL4 LY75 CD300E | 8.49e-04 | 394 | 137 | 10 | 471 |
| GeneFamily | Proteases, serine | 1.33e-03 | 63 | 137 | 4 | 738 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.55e-03 | 8 | 137 | 2 | 658 | |
| GeneFamily | Transglutaminases | 1.98e-03 | 9 | 137 | 2 | 773 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.98e-03 | 9 | 137 | 2 | 1230 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 3.00e-03 | 11 | 137 | 2 | 1156 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 8.05e-03 | 18 | 137 | 2 | 498 | |
| GeneFamily | Aldehyde dehydrogenases | 8.96e-03 | 19 | 137 | 2 | 398 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 8.96e-03 | 19 | 137 | 2 | 832 | |
| Coexpression | GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN | 3.33e-07 | 200 | 195 | 11 | M3416 | |
| Coexpression | NABA_ECM_REGULATORS | 1.85e-06 | 238 | 195 | 11 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 2.17e-06 | 242 | 195 | 11 | MM17062 | |
| Coexpression | ROVERSI_GLIOMA_COPY_NUMBER_UP | 1.01e-05 | 100 | 195 | 7 | M11028 | |
| Coexpression | GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 2.01e-05 | 200 | 195 | 9 | M9562 | |
| Coexpression | DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 2.64e-05 | 159 | 195 | 8 | M34031 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-07 | 195 | 196 | 9 | 25703e3c2e0512ef12e7aa389fad3968c3f13905 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-07 | 199 | 196 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-07 | 158 | 196 | 8 | 9f58428f70d1427b20122c5c1cc7bf521d0f4832 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.07e-06 | 174 | 196 | 8 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.70e-06 | 185 | 196 | 8 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | Control-Myeloid-MoAM5|Control / Disease group,lineage and cell class （2021.01.30） | 1.84e-06 | 187 | 196 | 8 | 8769341be67382cea2a590d962f4def7c39de883 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.84e-06 | 187 | 196 | 8 | 0d589de12108230ced5b60229564f4a181e2f172 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.84e-06 | 187 | 196 | 8 | 59d28f4ee1d463ae20abb8d7e7399b504d80698a | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.84e-06 | 187 | 196 | 8 | 25adf648c05c21534b4913254e73d43fc5f64e06 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.84e-06 | 187 | 196 | 8 | 3b0cfa9e5ea5e7d6dda689c328b9b5110b43ee1d | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-06 | 198 | 196 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-06 | 162 | 196 | 7 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 166 | 196 | 7 | 829a8998ce68739a58202851afd73e049ab0f84f | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 166 | 196 | 7 | c43aec09578975df8984886993d15b42a10190c8 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.06e-05 | 170 | 196 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.27e-05 | 175 | 196 | 7 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.27e-05 | 175 | 196 | 7 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 1.32e-05 | 176 | 196 | 7 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.37e-05 | 177 | 196 | 7 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | Control-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.53e-05 | 120 | 196 | 6 | 62d3a731d36802c9da8674a042a8604cdb86263a | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 183 | 196 | 7 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 183 | 196 | 7 | b12b89debc9dd6396188bc8fe44f54c01c560966 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 183 | 196 | 7 | 19cc0009f5332b6e4d4274df123eebbfc80b669a | |
| ToppCell | Control-B_naive-9|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.76e-05 | 123 | 196 | 6 | 36d509eae874733f1a4f8189ad3000136ff6425e | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-05 | 184 | 196 | 7 | 9365cdc52a2419e3f27e1c1c9310fa707d1e506b | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 196 | 7 | 7cc3b9bba1f600b40b02fe2456b5d007dbf9fa37 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-club_cell-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-05 | 184 | 196 | 7 | 204d16c48f822c98dc4118ac97a4f99f7e1163c8 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 196 | 7 | 53b71c4ac86dc5e42763b8f64fbc917177531017 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 185 | 196 | 7 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 188 | 196 | 7 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 188 | 196 | 7 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 188 | 196 | 7 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 189 | 196 | 7 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 189 | 196 | 7 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.09e-05 | 189 | 196 | 7 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 190 | 196 | 7 | e5625feb21915d4545cfad2659745ef180efcb1f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-05 | 190 | 196 | 7 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 190 | 196 | 7 | 0bad41d19dc515e6bc61e699f4d56664cf2e72fd | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.24e-05 | 191 | 196 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.32e-05 | 192 | 196 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-05 | 192 | 196 | 7 | d6ea34391c3f730684b82e912d9cf55e928b3311 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-05 | 193 | 196 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 196 | 7 | 22ebc3f586eb0aabc5785e468c88d7416c624ff4 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 196 | 7 | 1526f51b589a7dc7a28f35f0e788dc38d338d2bc | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.40e-05 | 193 | 196 | 7 | d9be4d1de863fffc2240d6fd1a2f8dfb2d2bc916 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.48e-05 | 194 | 196 | 7 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 194 | 196 | 7 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 194 | 196 | 7 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 194 | 196 | 7 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.56e-05 | 195 | 196 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-05 | 196 | 196 | 7 | 23e22dfb9f9aec17b83574295f889e75f46ded50 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 196 | 196 | 7 | 9554ac6eb5f381bcde3ba40c32aa3fc340974540 | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|COVID-19 / Condition, Lineage and Cell class | 2.73e-05 | 197 | 196 | 7 | 4a9c61b37c938bb26929593007d713382ae1eb79 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.73e-05 | 197 | 196 | 7 | 5bf4d964a9ee82002d3bc9ba1f020902eb96de7a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 198 | 196 | 7 | 0a4626b51ba8b52acbaf616f0ced850079cd7149 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 198 | 196 | 7 | 96236fa22545f6f4ff3aa8dc002963db8a3468ce | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 198 | 196 | 7 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 198 | 196 | 7 | 9e0fdd63069d17430cdc25bf4ffc762afd5e1728 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 198 | 196 | 7 | 7eb521af938c2609a85d27e2aa7d4317ad6e1e44 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-05 | 199 | 196 | 7 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.91e-05 | 199 | 196 | 7 | dbf0bf09896c46155ae6fbd6307f097799e7e34e | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-05 | 199 | 196 | 7 | 9314eb9a89407738626a0384884454b5f9031ee7 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-05 | 199 | 196 | 7 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-05 | 199 | 196 | 7 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-05 | 200 | 196 | 7 | eef5f6bd9ff5d985def8befcf45786234317f144 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-05 | 200 | 196 | 7 | 4b1ae9f71f0fe998b06fa580885572d1fc1544e2 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 3.81e-05 | 141 | 196 | 6 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | (05)_Ciliated-(1)_24hpi|(05)_Ciliated / shred by cell type and Timepoint | 4.36e-05 | 88 | 196 | 5 | 76959e7e3f6fae07c9881a29c28ba847be406694 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l8|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.18e-05 | 149 | 196 | 6 | 0f9d2209e8a02371b9f93c0a2fb6f79a4ce48ef1 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.58e-05 | 151 | 196 | 6 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.01e-05 | 153 | 196 | 6 | 489228ab81c3ae339a53a9da6c2a1c1b6ac3f84b | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 6.69e-05 | 156 | 196 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | COVID-19-APC-like-Alveolar_macrophages|COVID-19 / group, cell type (main and fine annotations) | 6.69e-05 | 156 | 196 | 6 | 735ade77cfa16b9386a0c7ec2bd14bd2e78a51ad | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 157 | 196 | 6 | 2b60de520edf167f5ca790b478557a778435b3d9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 157 | 196 | 6 | 0966e347f8d32b13f8a3b3afba3f64637c69cdf9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 157 | 196 | 6 | 6ebfedd91d62c6d4aa8f046657a899a279f82ba2 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 7.43e-05 | 159 | 196 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cbr2_(Mural.Rgs5Acta2.Cbr2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.65e-05 | 99 | 196 | 5 | 0e2f6ba2261cc289f8f4aec5aac3051f6321e041 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cbr2_(Mural.Rgs5Acta2.Cbr2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.65e-05 | 99 | 196 | 5 | ce9d6d9b82bdc1ebb58b0b6e04abfb022dd1de88 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-05 | 160 | 196 | 6 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.24e-05 | 162 | 196 | 6 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 165 | 196 | 6 | f8bfe336b9a4460b9349c01acd0bd3167812662f | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 165 | 196 | 6 | 95866f7cc6eb1bb51a034a104a0eb2a53b0256f2 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.74e-05 | 167 | 196 | 6 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | Control-Lymphocytic_B-B_cells-B-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.74e-05 | 167 | 196 | 6 | 69ed8a4a507190a1a66c4baf1f3e9be21ada39d8 | |
| ToppCell | Control-Lymphocytic_B-B_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.74e-05 | 167 | 196 | 6 | a15a70d3837b31cc83a2a9e3f1bbfd77a95f2312 | |
| ToppCell | Control-Lymphocytic_B|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.74e-05 | 167 | 196 | 6 | 956da82394fd6a9f45fc2031796f12cc889542cd | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 168 | 196 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 168 | 196 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 168 | 196 | 6 | f45dbcd7753117a3e41e1412bce2100d52fa7fd0 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-04 | 168 | 196 | 6 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 168 | 196 | 6 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 105 | 196 | 5 | 8f31edf4183587f5b53941475453c5aa49f10bbd | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 1.22e-04 | 174 | 196 | 6 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 174 | 196 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 174 | 196 | 6 | df5664da3b93c233509781429a9c6d7edf1b8944 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.22e-04 | 174 | 196 | 6 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.26e-04 | 175 | 196 | 6 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 175 | 196 | 6 | c6c0196875f3b5293083cda6718300806a801941 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 175 | 196 | 6 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| Drug | Aminocaproic Acid | 5.81e-07 | 3 | 191 | 3 | DB00513 | |
| Drug | aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A | 5.39e-06 | 192 | 191 | 10 | 6164_DN | |
| Drug | methylazoxymethyl-beta-D-glucosiduronic acid | 5.74e-06 | 5 | 191 | 3 | CID000149476 | |
| Drug | Factor Xiiib | 1.04e-05 | 35 | 191 | 5 | CID000126166 | |
| Drug | sacranoside A | 1.14e-05 | 6 | 191 | 3 | CID000177407 | |
| Drug | Desaa-fibrin | 3.16e-05 | 8 | 191 | 3 | CID000127263 | |
| Drug | Organometallic Compounds | 3.28e-05 | 44 | 191 | 5 | ctd:D009942 | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.99e-05 | 194 | 191 | 9 | 3460_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 4.33e-05 | 196 | 191 | 9 | 3789_DN | |
| Drug | Zoxazolamine [61-80-3]; Down 200; 23.8uM; MCF7; HT_HG-U133A | 4.68e-05 | 198 | 191 | 9 | 5390_DN | |
| Drug | AC1Q4Q30 | 4.70e-05 | 9 | 191 | 3 | CID000185818 | |
| Drug | deltaMID | 4.70e-05 | 9 | 191 | 3 | CID000192085 | |
| Drug | Cephapirin sodium salt [24356-60-3]; Up 200; 9uM; HL60; HT_HG-U133A | 4.87e-05 | 199 | 191 | 9 | 2730_UP | |
| Drug | imidazole-4-acetic acid | 5.04e-05 | 48 | 191 | 5 | CID000096215 | |
| Drug | NSC-270916 | 6.65e-05 | 82 | 191 | 6 | CID000002949 | |
| Drug | NSC106556 | 7.00e-05 | 2 | 191 | 2 | CID000267363 | |
| Drug | allylacetylene | 7.00e-05 | 2 | 191 | 2 | CID000522708 | |
| Drug | AC1L3ZSY | 7.00e-05 | 2 | 191 | 2 | CID000098102 | |
| Drug | 1-hydroxy-3,7-dimethoxyxanthone | 7.00e-05 | 2 | 191 | 2 | CID005488808 | |
| Drug | 6-fluorocholesterol | 7.00e-05 | 2 | 191 | 2 | CID000135206 | |
| Drug | 25-fluorocholesterol | 7.00e-05 | 2 | 191 | 2 | CID006454807 | |
| Drug | benzene-butanol | 7.00e-05 | 2 | 191 | 2 | CID000076889 | |
| Drug | torvanol A | 7.00e-05 | 2 | 191 | 2 | CID000639650 | |
| Drug | post-P | 7.00e-05 | 2 | 191 | 2 | CID000124939 | |
| Drug | 8-Hydroxyquinoline-beta-D-glucoside | 7.00e-05 | 2 | 191 | 2 | CID000152983 | |
| Drug | (-)-Ircinol A | 7.00e-05 | 2 | 191 | 2 | CID005276610 | |
| Drug | AC1L8KDY | 7.00e-05 | 2 | 191 | 2 | CID000382949 | |
| Drug | Ccris 6118 | 7.00e-05 | 2 | 191 | 2 | CID003085143 | |
| Drug | 3alpha-dihydrocadambine | 7.00e-05 | 2 | 191 | 2 | CID000162138 | |
| Drug | avenacoside B | 7.00e-05 | 2 | 191 | 2 | CID000441878 | |
| Drug | manzamine A N-oxide | 7.00e-05 | 2 | 191 | 2 | CID006480355 | |
| Drug | glucocheirolin | 7.00e-05 | 2 | 191 | 2 | CID000656530 | |
| Drug | AC1NSZ0V | 7.00e-05 | 2 | 191 | 2 | CID005320067 | |
| Drug | balanitoside | 7.00e-05 | 2 | 191 | 2 | CID000150711 | |
| Drug | 3-mat | 7.00e-05 | 2 | 191 | 2 | CID006453430 | |
| Drug | AC1LDLNP | 7.00e-05 | 2 | 191 | 2 | CID000620782 | |
| Drug | Me-6-BIO | 7.00e-05 | 2 | 191 | 2 | CID006538821 | |
| Drug | xestomanzamine A | 7.00e-05 | 2 | 191 | 2 | CID006481130 | |
| Drug | Purin-6-yl 6-deoxy-1-thio-beta-D-glucopyranoside | 7.00e-05 | 2 | 191 | 2 | CID000130740 | |
| Drug | CID11954280 | 7.00e-05 | 2 | 191 | 2 | CID011954280 | |
| Drug | 3beta-isodihydrocadambine | 7.00e-05 | 2 | 191 | 2 | CID000188431 | |
| Drug | phenthoate oxon | 7.00e-05 | 2 | 191 | 2 | CID000019398 | |
| Drug | Ambap529-66-8 | 7.00e-05 | 2 | 191 | 2 | CID003083619 | |
| Drug | DIMBOA-glucoside | 7.00e-05 | 2 | 191 | 2 | CID000441563 | |
| Drug | ircinal | 7.00e-05 | 2 | 191 | 2 | CID005270588 | |
| Drug | glucoside 1 | 7.00e-05 | 2 | 191 | 2 | CID006325268 | |
| Drug | theaspirane | 7.00e-05 | 2 | 191 | 2 | CID000061953 | |
| Drug | dimethylbellidifolin | 7.00e-05 | 2 | 191 | 2 | CID005487856 | |
| Drug | 3,4,6-tri-O-methyl-D-glucose | 7.00e-05 | 2 | 191 | 2 | CID000193713 | |
| Drug | luteone | 7.00e-05 | 2 | 191 | 2 | CID005281797 | |
| Drug | pyrrolidinium | 8.13e-05 | 85 | 191 | 6 | CID000031268 | |
| Drug | GH 9 | 9.13e-05 | 11 | 191 | 3 | CID005488162 | |
| Drug | indoxyl | 9.76e-05 | 55 | 191 | 5 | CID000050591 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.15e-04 | 174 | 191 | 8 | 7530_DN | |
| Drug | St. John's wort extract | 1.21e-04 | 12 | 191 | 3 | CID000323959 | |
| Drug | AD 288 | 1.98e-04 | 14 | 191 | 3 | CID000073553 | |
| Drug | tranexamic acid | 2.01e-04 | 64 | 191 | 5 | CID000005526 | |
| Drug | NSC103055 | 2.09e-04 | 3 | 191 | 2 | CID000266052 | |
| Drug | digalloylresveratrol | 2.09e-04 | 3 | 191 | 2 | ctd:C534866 | |
| Drug | torvoside H | 2.09e-04 | 3 | 191 | 2 | CID000639649 | |
| Drug | 5-benzyloxyindole | 2.09e-04 | 3 | 191 | 2 | CID000014624 | |
| Drug | NSC721382 | 2.09e-04 | 3 | 191 | 2 | CID000404838 | |
| Drug | 2',4'-dinitrophenyl beta-D-galactopyranoside | 2.09e-04 | 3 | 191 | 2 | CID000152809 | |
| Drug | AC1Q5X08 | 2.09e-04 | 3 | 191 | 2 | CID000125153 | |
| Drug | FU-O-G | 2.09e-04 | 3 | 191 | 2 | CID000125172 | |
| Drug | protogracillin | 2.09e-04 | 3 | 191 | 2 | CID000441892 | |
| Drug | bioside | 2.09e-04 | 3 | 191 | 2 | CID003084119 | |
| Drug | nitroguanil | 2.09e-04 | 3 | 191 | 2 | CID000005822 | |
| Drug | Tp 9201 | 2.09e-04 | 3 | 191 | 2 | CID000160029 | |
| Drug | AC1L2O6A | 2.09e-04 | 3 | 191 | 2 | CID000100152 | |
| Drug | Cellobiose octaacetate | 2.09e-04 | 3 | 191 | 2 | CID000104455 | |
| Drug | phloroglucinaldehyde | 2.09e-04 | 3 | 191 | 2 | CID000068099 | |
| Drug | 6-bromo-2-naphthyl-beta-d-glucoside | 2.09e-04 | 3 | 191 | 2 | CID000084983 | |
| Drug | 3'-galactosyllactose | 2.09e-04 | 3 | 191 | 2 | CID000189088 | |
| Drug | nPlg | 2.09e-04 | 3 | 191 | 2 | CID000092225 | |
| Drug | virgaureasaponin | 2.09e-04 | 3 | 191 | 2 | CID006324777 | |
| Drug | C7UGlc | 2.09e-04 | 3 | 191 | 2 | CID000127569 | |
| Drug | Tetraethyl Lead | 2.09e-04 | 3 | 191 | 2 | ctd:D013756 | |
| Drug | picein | 2.09e-04 | 3 | 191 | 2 | CID000092123 | |
| Drug | AC1O6AB3 | 2.09e-04 | 3 | 191 | 2 | CID006449878 | |
| Drug | 5-phenylpentanol | 2.09e-04 | 3 | 191 | 2 | CID000061523 | |
| Drug | AC1L9MOG | 2.09e-04 | 3 | 191 | 2 | CID000422690 | |
| Drug | AC1L1C5B | 2.09e-04 | 3 | 191 | 2 | CID000026918 | |
| Drug | N-bromoacetyl-beta-D-galactosylamine | 2.09e-04 | 3 | 191 | 2 | CID000193108 | |
| Drug | bellidifolin | 2.09e-04 | 3 | 191 | 2 | CID005281623 | |
| Drug | norswertianolin | 2.09e-04 | 3 | 191 | 2 | CID005281659 | |
| Drug | swertianolin | 2.09e-04 | 3 | 191 | 2 | CID005281662 | |
| Drug | estrone glucoside | 2.09e-04 | 3 | 191 | 2 | CID000193609 | |
| Drug | dioscine | 2.09e-04 | 3 | 191 | 2 | CID000120694 | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A | 2.25e-04 | 192 | 191 | 8 | 2722_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; PC3; HT_HG-U133A | 2.33e-04 | 193 | 191 | 8 | 2055_UP | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.41e-04 | 194 | 191 | 8 | 3938_DN | |
| Drug | Pyrithyldione [77-04-3]; Down 200; 24uM; HL60; HT_HG-U133A | 2.50e-04 | 195 | 191 | 8 | 2740_DN | |
| Disease | r-spondin-3 measurement | 5.50e-08 | 7 | 188 | 4 | EFO_0021878 | |
| Disease | Kabuki syndrome (implicated_via_orthology) | 2.55e-07 | 3 | 188 | 3 | DOID:0060473 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | GABRP CTU2 ABCA4 RAPH1 OBSCN CFHR5 HPSE MAP3K1 FASN NECTIN2 HERC2 RCCD1 ARF1 KMT2D LOXL2 NISCH CHEK2 ATM OCLN VPS13B DOP1A | 5.52e-06 | 1074 | 188 | 21 | C0006142 |
| Disease | clusterin measurement | 8.74e-06 | 7 | 188 | 3 | EFO_0007655 | |
| Disease | Deep Vein Thrombosis | 8.78e-06 | 21 | 188 | 4 | C0149871 | |
| Disease | Venous Thrombosis | 8.78e-06 | 21 | 188 | 4 | C0042487 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 9.89e-06 | 45 | 188 | 5 | DOID:3748 (is_implicated_in) | |
| Disease | Breast Carcinoma | CTU2 HPSE MAP3K1 FASN NECTIN2 HERC2 RCCD1 ARF1 KMT2D LOXL2 NISCH CHEK2 ATM OCLN | 1.01e-05 | 538 | 188 | 14 | C0678222 |
| Disease | melanoma | 1.70e-05 | 126 | 188 | 7 | EFO_0000756 | |
| Disease | Alzheimer disease, polygenic risk score | PRSS16 CBLC STK3 CLPTM1 NECTIN2 SDK1 PRSS12 FNBP4 CR1 RNF123 SF3B3 GOLPH3L LY75 EPB42 | 2.60e-05 | 586 | 188 | 14 | EFO_0030082, MONDO_0004975 |
| Disease | f-box/LRR-repeat protein 4 measurement | 2.96e-05 | 10 | 188 | 3 | EFO_0802538 | |
| Disease | Squamous cell carcinoma of esophagus | 3.35e-05 | 95 | 188 | 6 | C0279626 | |
| Disease | Mammary Carcinoma, Human | CTU2 HPSE MAP3K1 FASN NECTIN2 RCCD1 ARF1 KMT2D LOXL2 NISCH CHEK2 ATM OCLN | 3.52e-05 | 525 | 188 | 13 | C4704874 |
| Disease | Mammary Neoplasms, Human | CTU2 HPSE MAP3K1 FASN NECTIN2 RCCD1 ARF1 KMT2D LOXL2 NISCH CHEK2 ATM OCLN | 3.52e-05 | 525 | 188 | 13 | C1257931 |
| Disease | Mammary Neoplasms | CTU2 HPSE MAP3K1 FASN NECTIN2 RCCD1 ARF1 KMT2D LOXL2 NISCH CHEK2 ATM OCLN | 3.66e-05 | 527 | 188 | 13 | C1458155 |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 4.04e-05 | 2 | 188 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | Kabuki syndrome 1 | 4.04e-05 | 2 | 188 | 2 | cv:CN030661 | |
| Disease | Kabuki syndrome (is_implicated_in) | 4.04e-05 | 2 | 188 | 2 | DOID:0060473 (is_implicated_in) | |
| Disease | level of protocadherin-12 in blood serum | 4.04e-05 | 2 | 188 | 2 | OBA_2042780 | |
| Disease | KABUKI SYNDROME 1 | 4.04e-05 | 2 | 188 | 2 | 147920 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 6.55e-05 | 107 | 188 | 6 | EFO_0004614, EFO_0004615 | |
| Disease | free cholesterol measurement | 8.87e-05 | 113 | 188 | 6 | EFO_0008591 | |
| Disease | drinking behavior | 1.21e-04 | 3 | 188 | 2 | EFO_0004315 | |
| Disease | diacylglycerol kinase beta measurement | 1.21e-04 | 3 | 188 | 2 | EFO_0801525 | |
| Disease | NF-kappa-B essential modulator measurement | 1.21e-04 | 3 | 188 | 2 | EFO_0010597 | |
| Disease | bcl-2-like protein 2 measurement | 1.21e-04 | 3 | 188 | 2 | EFO_0021928 | |
| Disease | tensin-2 measurement | 1.21e-04 | 3 | 188 | 2 | EFO_0802122 | |
| Disease | glucose-6-phosphate isomerase measurement | 1.21e-04 | 3 | 188 | 2 | EFO_0020407 | |
| Disease | Kabuki make-up syndrome | 2.40e-04 | 4 | 188 | 2 | C0796004 | |
| Disease | sorting nexin-1 measurement | 2.40e-04 | 4 | 188 | 2 | EFO_0803092 | |
| Disease | Glycogen phosphorylase kinase deficiency | 2.40e-04 | 4 | 188 | 2 | cv:C0268147 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 2.40e-04 | 4 | 188 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | prolyl 4-hydroxylase subunit alpha-2 measurement | 2.40e-04 | 4 | 188 | 2 | EFO_0802918 | |
| Disease | coagulation factor measurement | 2.68e-04 | 20 | 188 | 3 | EFO_0004634 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.97e-04 | 91 | 188 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 3.99e-04 | 5 | 188 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | galectin-1 measurement | 3.99e-04 | 5 | 188 | 2 | EFO_0020932 | |
| Disease | plasma plasminogen measurement | 3.99e-04 | 5 | 188 | 2 | EFO_0006309 | |
| Disease | lysophosphatidylcholine acyltransferase 2 measurement | 3.99e-04 | 5 | 188 | 2 | EFO_0801775 | |
| Disease | brain infarction (is_implicated_in) | 3.99e-04 | 5 | 188 | 2 | DOID:3454 (is_implicated_in) | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 3.99e-04 | 5 | 188 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 4.39e-04 | 99 | 188 | 5 | EFO_0004574, EFO_0008595 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 5.50e-04 | 104 | 188 | 5 | EFO_0008591, EFO_0008595 | |
| Disease | dynactin subunit 2 measurement | 5.96e-04 | 6 | 188 | 2 | EFO_0020338 | |
| Disease | complement component 1 q subcomponent-binding protein, mitochondrial measurement | 5.96e-04 | 6 | 188 | 2 | EFO_0020280 | |
| Disease | galectin-7 measurement | 5.96e-04 | 6 | 188 | 2 | EFO_0022034 | |
| Disease | amyloid beta A4 precursor protein-binding family B member 2 measurement | 5.96e-04 | 6 | 188 | 2 | EFO_0801379 | |
| Disease | Noonan syndrome (is_marker_for) | 5.96e-04 | 6 | 188 | 2 | DOID:3490 (is_marker_for) | |
| Disease | nischarin measurement | 5.96e-04 | 6 | 188 | 2 | EFO_0801841 | |
| Disease | interleukin-23 receptor measurement | 5.96e-04 | 6 | 188 | 2 | EFO_0801725 | |
| Disease | angiostatin measurement | 5.96e-04 | 6 | 188 | 2 | EFO_0008024 | |
| Disease | remnant cholesterol measurement | 6.53e-04 | 108 | 188 | 5 | EFO_0010815 | |
| Disease | triglycerides in small HDL measurement | 6.67e-04 | 62 | 188 | 4 | EFO_0022158 | |
| Disease | Malignant neoplasm of stomach | 7.15e-04 | 300 | 188 | 8 | C0024623 | |
| Disease | aspartate aminotransferase measurement | CFH ABCA4 STARD10 OBSCN IPP HMCN2 ALDH2 ATG16L2 CACNA1S HECTD4 GBA3 NPHP3 SLC22A1 CHEK2 LY75 | 7.20e-04 | 904 | 188 | 15 | EFO_0004736 |
| Disease | lung small cell carcinoma (is_implicated_in) | 7.42e-04 | 28 | 188 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | monocyte count | FCRL2 AAMP AHI1 LYST CDKAL1 ZNF276 PTPRA FCGR1A PTPRH PLG DCAF12 CRYBG2 CD300LF MED13L GSK3A GSK3B LPA ATM FCRL4 | 8.13e-04 | 1320 | 188 | 19 | EFO_0005091 |
| Disease | 1,5 anhydroglucitol measurement | 8.23e-04 | 29 | 188 | 3 | EFO_0008009 | |
| Disease | pleckstrin homology domain-containing family A member 1 measurement | 8.30e-04 | 7 | 188 | 2 | EFO_0802873 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 8.30e-04 | 7 | 188 | 2 | EFO_0020797 | |
| Disease | anosmin-1 measurement | 8.30e-04 | 7 | 188 | 2 | EFO_0802284 | |
| Disease | hereditary angioedema (is_implicated_in) | 8.30e-04 | 7 | 188 | 2 | DOID:14735 (is_implicated_in) | |
| Disease | complement C1r subcomponent measurement | 8.30e-04 | 7 | 188 | 2 | EFO_0008090 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 8.30e-04 | 7 | 188 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | Henoch-Schoenlein purpura (is_marker_for) | 8.30e-04 | 7 | 188 | 2 | DOID:11123 (is_marker_for) | |
| Disease | esophageal carcinoma | 9.10e-04 | 30 | 188 | 3 | EFO_0002916 | |
| Disease | Benign Neoplasm | 9.46e-04 | 68 | 188 | 4 | C0086692 | |
| Disease | Neoplasms | 9.46e-04 | 68 | 188 | 4 | C0027651 | |
| Disease | glycoprotein measurement | 1.01e-03 | 119 | 188 | 5 | EFO_0004555 | |
| Disease | obsolete_red blood cell distribution width | AHI1 GARS1 ZFYVE1 MAP3K1 PTPRA PTPRH VPS33B CLPTM1 TM4SF18 ALDH2 HERC1 DCAF12 CD300LF RCCD1 HECTD4 BCCIP GBA2 RNF123 CHEK2 | 1.03e-03 | 1347 | 188 | 19 | EFO_0005192 |
| Disease | cadherin-related family member 5 measurement | 1.10e-03 | 8 | 188 | 2 | EFO_0801440 | |
| Disease | female breast cancer (is_implicated_in) | 1.10e-03 | 8 | 188 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Dermatitis, Occupational | 1.10e-03 | 8 | 188 | 2 | C0028796 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 1.10e-03 | 8 | 188 | 2 | EFO_0008309 | |
| Disease | Hereditary spherocytosis | 1.10e-03 | 8 | 188 | 2 | C0037889 | |
| Disease | basal cell adhesion molecule measurement | 1.10e-03 | 8 | 188 | 2 | EFO_0008032 | |
| Disease | Industrial Dermatosis | 1.10e-03 | 8 | 188 | 2 | C0086457 | |
| Disease | family history of Alzheimer’s disease | 1.11e-03 | 71 | 188 | 4 | EFO_0009268 | |
| Disease | lymphocyte count | RAPH1 EML6 LYST PSME4 PTPRH NECTIN2 DMBT1 DCAF12 SEL1L CACNA1S CD300LF HECTD4 MED13L PTPRT LSR GOLPH3L PCDHGA12 CD38 CHEK2 ATM | 1.12e-03 | 1464 | 188 | 20 | EFO_0004587 |
| Disease | Complement deficiency disease | 1.21e-03 | 33 | 188 | 3 | C0272242 | |
| Disease | angina pectoris | 1.26e-03 | 125 | 188 | 5 | EFO_0003913 | |
| Disease | granulocyte count | 1.27e-03 | 254 | 188 | 7 | EFO_0007987 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 1.30e-03 | 126 | 188 | 5 | EFO_0004611, EFO_0010351 | |
| Disease | plasma betaine measurement | 1.32e-03 | 34 | 188 | 3 | EFO_0007787 | |
| Disease | Mental deterioration | 1.41e-03 | 9 | 188 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 1.41e-03 | 9 | 188 | 2 | C1270972 | |
| Disease | C3 glomerulopathy | 1.41e-03 | 9 | 188 | 2 | C4087273 | |
| Disease | tyrosine-protein phosphatase non-receptor type 4 measurement | 1.41e-03 | 9 | 188 | 2 | EFO_0802172 | |
| Disease | glycogen storage disease (is_implicated_in) | 1.41e-03 | 9 | 188 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | Manic | 1.58e-03 | 78 | 188 | 4 | C0338831 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.69e-03 | 37 | 188 | 3 | EFO_0022252 | |
| Disease | Peripheral T-Cell Lymphoma | 1.76e-03 | 10 | 188 | 2 | C0079774 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_20:4) in blood serum | 1.76e-03 | 10 | 188 | 2 | OBA_2045148 | |
| Disease | adseverin measurement | 1.76e-03 | 10 | 188 | 2 | EFO_0801358 | |
| Disease | creatinine measurement | CFH DCDC1 SIPA1L3 OBSCN GOLPH3 BRWD3 F13A1 NECTIN2 KNG1 DCAF12 CACNA1S RNF123 GOLPH3L LPA SLC22A1 | 1.86e-03 | 995 | 188 | 15 | EFO_0004518 |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.89e-03 | 137 | 188 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | skin pigmentation measurement | 1.89e-03 | 137 | 188 | 5 | EFO_0007009 | |
| Disease | Colorectal Carcinoma | ABCA4 OBSCN IPP KMT2C ALDH2 KDM6A WDR49 CAD HTR5A PTPRT CHEK2 CD300E | 1.91e-03 | 702 | 188 | 12 | C0009402 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.01e-03 | 139 | 188 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 2.07e-03 | 140 | 188 | 5 | C0005695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FIYCSDTGWAVGTEE | 46 | Q9NXW9 | |
| IYLGTADCIQAESWD | 166 | P16452 | |
| GSCDGALYIWDVDTG | 566 | Q8NAA4 | |
| GLSNYAAWEVAEICT | 141 | Q8NHP1 | |
| GLSNYAAWEVAEICT | 141 | O95154 | |
| EQGSLTVQCAYGSGW | 31 | Q6UXZ3 | |
| SCTRLGQWAIGYVSS | 266 | Q9ULV8 | |
| QESYWLGGEGCSTRE | 876 | P78363 | |
| ENGEICLECTSVGWY | 156 | Q13410 | |
| WEAGTAVVYTCSLDG | 366 | Q13685 | |
| SGDCTGVIVVWNTYV | 761 | Q8N157 | |
| TGLWVGDCFIYTSSV | 526 | P35606 | |
| TQYGSSVDIWAIGCV | 176 | Q5MAI5 | |
| GTAGDSLTVWCQYES | 26 | Q496F6 | |
| SGSYWCGAETVRGNI | 256 | Q96PJ5 | |
| SALESGTVWINCYNA | 456 | P47895 | |
| FCQDISGWTAEDYAV | 231 | A6NC57 | |
| RYLTSTGADGTICFW | 281 | Q6RI45 | |
| RNWYIQATCATSGDG | 151 | P61204 | |
| SDGLDLENWYSCGEG | 1326 | Q5JWR5 | |
| LENWYSCGEGDISEI | 1331 | Q5JWR5 | |
| IAEEIYGGISDCWAD | 51 | Q8WXH4 | |
| LGEINYRECDTDGWT | 121 | P08603 | |
| STTGSIVCGYNGWSD | 546 | P08603 | |
| TICWNDTGEYILSGS | 56 | Q58WW2 | |
| LEVYFQGRWGTVCDD | 596 | Q9NR16 | |
| TAGYNRAVDCWSLGV | 401 | O96017 | |
| ESEQGVYTCTAQGIW | 421 | P00736 | |
| TLENLTEEDAGTYWC | 96 | Q08708 | |
| TEEDAGTYWCGVDTP | 101 | Q08708 | |
| GYLADDLTWCGEFNT | 151 | P28907 | |
| HSVCVSETGDIYIWG | 221 | A6NED2 | |
| WTSVFDDSIISACGY | 381 | Q6ZP01 | |
| CGYSLDWSLVETVSE | 306 | Q70E73 | |
| RGTAIEYSTGCEIDW | 321 | Q9ULW6 | |
| YWLDCLQDAGSDGVV | 926 | Q7Z6P3 | |
| AALNDCIYSVGGWNE | 481 | Q9Y573 | |
| CIYSVGGWNETQDAL | 486 | Q9Y573 | |
| ACVASTLAWDRGYGT | 81 | Q16625 | |
| GTLWETGCTQIRYSV | 21 | O60330 | |
| VVGSYAWGVSCSLEL | 146 | Q8NGL1 | |
| AYQSSVWLGTEDGCV | 1736 | Q96PE2 | |
| VWLGTEDGCVHVYQS | 1741 | Q96PE2 | |
| CWSLVVGAYVCGVSG | 141 | Q8NGQ6 | |
| QQYSSGGVGCVVWDA | 31 | Q9H867 | |
| DSQKWVFGTDGCIYS | 751 | M0R2J8 | |
| ESLCALVASQYGWSG | 281 | Q58FF3 | |
| GTVEVYASGVWGTVC | 181 | P56730 | |
| TASNCYITGWGDTGR | 761 | P56730 | |
| ILWGDAGYTTSTETC | 326 | Q12891 | |
| DVLTVECYSPATGQW | 531 | Q9H511 | |
| GTYTCEAWNSAGEVR | 691 | Q15746 | |
| NCALWSTEVYETQAG | 4431 | Q8NEZ4 | |
| EEGLWENGLSYECRT | 106 | Q71F56 | |
| IESGTSVYCNCTTGW | 2626 | Q5T1H1 | |
| DWTCVTLATYSGGST | 151 | P61550 | |
| CLALSSEGEVYSWGE | 4051 | O95714 | |
| DGDSNCEWSVLYVII | 921 | Q8IZA0 | |
| VSREDSGTYVCWAEN | 4181 | Q8NDA2 | |
| YNTKTCATVVGDDQW | 116 | P46020 | |
| ENGGFCTSAGALWIY | 71 | Q8IYD8 | |
| PIVSETCEVYVWGSN | 366 | Q15751 | |
| SLALTSTGQVYAWGC | 626 | Q15751 | |
| ASADTWCSIGVLYQQ | 316 | O15550 | |
| YDGQWGTVCDDDFSI | 76 | Q9Y4K0 | |
| YSVQEESDTCLGGKW | 266 | Q9P287 | |
| FDGYVIDGATALWCA | 81 | Q9UK73 | |
| GNCFTAGEAVDWLYD | 41 | Q5TB30 | |
| VGCAGDETESQDYWK | 61 | P12525 | |
| FWTGLRDVDSCGEYN | 556 | O60449 | |
| RDVDSCGEYNWATVG | 561 | O60449 | |
| WSYGQFEDGILDTCL | 226 | P00488 | |
| VYEVSVGSCQGNWTA | 211 | Q8NCW0 | |
| ECWGGGEYATATATI | 116 | O43766 | |
| QNGYDESCDLWSLGV | 596 | O75582 | |
| QQGYDAACDIWSLGV | 596 | Q9UK32 | |
| EISSGCYEGLQWLDE | 21 | Q92985 | |
| DCVSYITGASGSTWA | 326 | P0C869 | |
| YDEETQNWVSGGACG | 2801 | Q9Y4D8 | |
| DTVTYLSGVSGSTWC | 386 | Q68DD2 | |
| GDDCWVNLSYTVVAF | 606 | Q8IYI6 | |
| LGWDSEEVRQTCGYT | 141 | Q9Y693 | |
| CSSKGYNISWELGNE | 211 | Q9Y251 | |
| CGYSVALGTNGFTWE | 41 | O14522 | |
| AWDLDSGTNGEICYT | 266 | Q9Y5F2 | |
| VTYIVQCSLEGGSWT | 7586 | Q5VST9 | |
| LWVSCGAAAGQLEYS | 11 | Q9H158 | |
| YGLLTTEASAVWACD | 366 | Q9BRQ0 | |
| LWYCDLQQESSGIAG | 261 | P48147 | |
| VYCEIDGSGNGWTVF | 206 | P02679 | |
| YNSVSCGVSEWQLEE | 2281 | Q13315 | |
| DYTSSIDVWSAGCVL | 296 | P49840 | |
| SEEEWNTGETYTCVV | 401 | P01871 | |
| EYSSELDIWGAGCIF | 276 | Q96Q40 | |
| IYCTSKDDQVGVWSS | 1566 | P17927 | |
| GLTWEGFQTAEGCYR | 836 | Q9HCG7 | |
| NQTGDVACGSYTLWE | 46 | Q9H227 | |
| TGEAWQEILLACSYG | 1321 | Q13698 | |
| CLAYGSEWSVYAVGS | 301 | Q5T6F0 | |
| EQVVAGSYSFTWLCS | 261 | Q9BQN1 | |
| YAQACLELGISVGDW | 721 | Q9Y6R7 | |
| CEIWLTSEDTGAYGR | 251 | Q5VV42 | |
| NVDWGEIRGFETAYC | 531 | Q86SF2 | |
| TDADTYWCGIEKTGN | 101 | Q8TDQ1 | |
| VGSCEITNWLTYSGT | 1501 | Q8N1P7 | |
| VHCWYTGTLQDGTVF | 131 | Q00688 | |
| EGYTSFWNDCISSGL | 61 | Q9H4A5 | |
| ATDYTSSIDVWSAGC | 231 | P49841 | |
| VCQGDSGSVYVVWDN | 431 | Q9NZP8 | |
| GYTSFWNDCISSGLR | 76 | Q9H4A6 | |
| WGETYSEGSEECQVS | 181 | P47898 | |
| RNWYIQATCATSGDG | 151 | P84077 | |
| TECYITGWGETQGTF | 1936 | P08519 | |
| KYGWSADESGQIFIC | 176 | Q9UBQ5 | |
| RVGSDSVQCYQFGWS | 181 | Q9BXR6 | |
| LYTANSDGTVIAWCR | 3766 | Q99698 | |
| GLYWCEAATEDGNVL | 256 | P12314 | |
| LWNGDTGECTDNAYI | 221 | P01042 | |
| YVVSTGGDDCSVFVW | 1941 | Q6ZMW3 | |
| CSVAGGTGNVTFSWY | 226 | Q96LA5 | |
| DGCLSQEEAVLAAYW | 591 | P49327 | |
| ECVLYTGWIERASGS | 21 | Q8IZY5 | |
| EILYRGSWGTVCDDS | 116 | Q9UGM3 | |
| VEVLYRGSWGTVCDD | 376 | Q9UGM3 | |
| EVLYRGSWGTVCDDS | 616 | Q9UGM3 | |
| VEVLYRGSWGTVCDD | 746 | Q9UGM3 | |
| EVLYRGSWGTVCDDS | 876 | Q9UGM3 | |
| VEVLYQGSWGTVCDD | 1006 | Q9UGM3 | |
| EVLYRGSWGTVCDDY | 1136 | Q9UGM3 | |
| RVEVLYQGSWGTVCD | 1521 | Q9UGM3 | |
| QTWSGDIGDYSCEIV | 636 | Q7Z5N4 | |
| ISQTWSGDIGTYTCR | 556 | Q58EX2 | |
| CQDGWVYDTPGSSIV | 121 | O15245 | |
| ATEPCTDGWIYDNST | 101 | Q4U2R8 | |
| YGADGTLCWSRFTQI | 326 | H0Y7S4 | |
| WCSAQELVGSEGAYK | 161 | Q2VPK5 | |
| TQTCKLQLESWGYDG | 171 | O00591 | |
| YNTATCGTVVGDDQW | 116 | P46019 | |
| DQTAWGDSGVYYCSV | 206 | Q86X29 | |
| DQGCWTYGNIRVSVE | 356 | P18433 | |
| CGVTDTNSYAAWAER | 91 | Q9H239 | |
| VDGDRAVCGSYSFTW | 261 | A6ND36 | |
| YGRSCDVWSVGCAII | 1426 | Q13233 | |
| GYNELCDIWSLGITA | 191 | Q92918 | |
| TVLNSYSGWALCAEG | 836 | Q13423 | |
| ALRWSSVEAVCGYGS | 71 | Q9Y6J9 | |
| VGCTNSSWVLLYTAQ | 2126 | O75445 | |
| SEASADTWCSIGVLY | 311 | O14607 | |
| TLCLESQGLSGYDWC | 146 | Q8N808 | |
| GYDIVGSDTLTCQWD | 776 | Q9BYH1 | |
| ECEAEVGWNLTYSRA | 36 | Q9Y365 | |
| YWAGIGVLQSCESAL | 301 | Q9UBV2 | |
| NDCWVSTGLYLLEGQ | 541 | A6NFQ2 | |
| GWQYDTQCSLAGVGI | 201 | Q8N3X1 | |
| DVTAAGTQCEYWTGG | 221 | Q7Z494 | |
| SLDSCEYIWEAGVGF | 176 | Q8IV36 | |
| TSYGWIEIVGCADRS | 451 | P41250 | |
| CWNEVFIGYGSALGS | 291 | Q7Z3Q1 | |
| SYGADGTLCWSRFTQ | 421 | A6NGN4 | |
| GVQGSCWEYNVTSFR | 721 | Q9H2Y9 | |
| EVVFNCYCGDVIGWT | 906 | O60292 | |
| VSGWSETVEFCTGDY | 101 | Q92561 | |
| YVVADRTECFITGWG | 691 | P00747 | |
| NEGYELVGDSSWTCQ | 2291 | Q4LDE5 | |
| GCWAFSVVGAVESAY | 131 | P43234 | |
| GTVWVNCYDVFGAQS | 466 | P05091 | |
| YDIAWCQLTGALATA | 256 | O76071 | |
| ENLTEEDAGTYWCGV | 91 | Q9UGN4 | |
| LVYGDWTSGENSDGC | 131 | O96005 | |
| SQVLSGYDWCGLLGS | 151 | P0C7Q5 | |
| WIVMEYCGAGSVSDI | 96 | Q13188 | |
| IGYNCVADIWSLGIT | 196 | Q13188 | |
| WGDQYSAECGESSFL | 81 | Q8NBP0 | |
| QWGGVFYAEIKSSCA | 161 | O94966 | |
| SYDGLCRIWDAASGQ | 186 | Q86VZ2 | |
| TCYEDQGISYRGTWS | 126 | P00750 | |
| TGDIVSCAGTYIHVW | 3181 | Q8IZQ1 | |
| TCTAIGEPESIDWYN | 41 | O15394 | |
| VGSAYCGASVISREW | 626 | Q7RTY8 | |
| CRTLDGWEYAFEGTA | 121 | Q96CE8 | |
| TNYGKAWAAGDIVSC | 186 | Q5XPI4 | |
| GVITEYQIWCLGNES | 801 | Q96MS0 | |
| STDGTVKIWDFNGYC | 211 | Q8IV35 | |
| AAGDYSGNIEWASCT | 871 | Q9Y2I1 | |
| SSEYCGVIQVVWGCD | 221 | Q8N554 | |
| YGSRCVDITGNIFWT | 291 | A0A1W2PR48 | |
| DSGGRLACEYNDTWV | 266 | Q7Z5A4 | |
| SCGEWKSLVGATYVE | 276 | Q8IYQ7 | |
| VEDCSGIQFAPYTWS | 281 | Q15814 | |
| ITVETYNDWGACIAT | 1416 | Q14997 | |
| TLCLESQGLSGYDWC | 146 | P0C7Q6 | |
| VAVCRFSNTGEDWYV | 891 | Q15393 | |
| GVYRIGSSVEFDWCA | 941 | P27708 | |
| SPTQESCTVGVWAAY | 211 | Q9HBF4 | |
| LLTGSEDGCVYGWET | 36 | Q5JTN6 | |
| VNITSAECYTVGELW | 171 | Q7Z7G8 | |
| SQVYGAVAEWLRECG | 371 | Q63HK3 | |
| YNCVADIWSLGITAI | 201 | Q13043 | |
| QEYVKSSAWETGENC | 611 | Q13395 | |
| EQLLVYSCEAWGGSN | 641 | Q7Z2W7 | |
| GASCIDISDYGTRLW | 591 | Q04725 | |
| GSDYWLLATEVGRCS | 26 | Q6ZP80 | |
| SNYWVQCTGDGGTTE | 61 | Q9HD43 | |
| SLYTCSVWVEKDGVN | 271 | Q9HD43 | |
| VVGCSDGSVYVWQMD | 576 | Q9Y4E6 | |
| SGVGDRQWLYQTCTE | 366 | Q9NQE7 | |
| TYCGNICWINVETSG | 71 | Q8NEX6 | |
| GIYGDVSCDEWAFSL | 131 | Q9H267 | |
| WSGCQVVSEEGTRYL | 116 | Q8NBT3 | |
| NCALWSTEVYETQGG | 5061 | O14686 | |
| WDSQSYDIEQICLGA | 136 | A8MZ59 | |
| GYFVDRCEVGTNNWV | 416 | P54296 | |
| AYTIERCQGESGEWI | 406 | Q5VTT5 | |
| NWYLGRTDATLSCDV | 271 | Q92692 |